Dapsita-10/100 with Dapagliflozin 10 mg + Sitagliptin 100 mg

Product Name: Dapsita-10/100 Tablet

Manufacturer: Integrum Healthcare Private Limited

Composition:

• Dapagliflozin 10 mg
• Sitagliptin Phosphate 100 mg

Description: Dapsita-10/100 Tablet is a breakthrough formulation meticulously crafted to manage blood sugar levels in individuals with type 2 diabetes mellitus. This innovative combination brings together the synergistic benefits of dapagliflozin and sitagliptin phosphate, two potent antidiabetic agents, to provide comprehensive glycemic control and improve overall health outcomes.

Key Ingredients of Dapsita-10/100:

1. Dapagliflozin: Dapagliflozin belongs to a class of medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by inhibiting the reabsorption of glucose in the kidneys, thereby promoting the excretion of excess glucose through urine. This mechanism helps lower blood sugar levels and reduces the risk of cardiovascular events in diabetic patients.
2. Sitagliptin Phosphate: Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances the activity of incretin hormones, which stimulate insulin secretion and inhibit glucagon release. By prolonging the action of incretins, sitagliptin phosphate helps regulate blood glucose levels, particularly after meals, without causing hypoglycemia.

Benefits of Dapsita-10/100:

• Dual Action: The combination of dapagliflozin and sitagliptin phosphate offers complementary mechanisms of action to effectively lower blood sugar levels by reducing glucose reabsorption and enhancing insulin secretion, resulting in improved glycemic control.
• Cardiorenal Protection: Dapagliflozin has demonstrated cardiovascular and renal benefits beyond glycemic control, including reduced risk of heart failure hospitalization and progression of kidney disease, making Dapsita-10/100 Tablet a valuable addition to comprehensive diabetes management.
• Convenience: Dapsita-10/100 Tablet provides the convenience of a single-tablet regimen, simplifying medication adherence and improving patient compliance, thereby enhancing treatment efficacy and long-term health outcomes.

Directions for Use: Take one Dapsita-10/100 Tablet orally, with or without food, as directed by your healthcare provider. Swallow the tablet whole with a glass of water. Do not crush, chew, or break the tablet unless advised otherwise by your doctor.

Precautions:

• Follow your doctor’s instructions regarding dosage and frequency of administration.
• Inform your healthcare provider about any other medications, supplements, or medical conditions you have before starting Dapsita-10/100 Tablet.
• Monitor blood sugar levels regularly as advised by your doctor.
• If you experience any adverse effects or allergic reactions, discontinue use and seek medical attention immediately.

Packaging: The Tablet is available in a securely sealed blister pack to ensure product integrity and potency. Each pack contains 10 tablets.

Manufacturer Information: Manufactured by Integrum Healthcare Private Limited [Insert Address] [Insert Contact Information]

Disclaimer: Dapsita-10/100 Tablet is a prescription medication used for the management of type 2 diabetes mellitus. It should be used under the supervision of a qualified healthcare professional. This product is not intended to diagnose, treat, cure, or prevent any disease.

Substitutes for Dapsita-10/100